Ingenus Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INGENUS PHARMS LLC, and what generic alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has ten approved drugs.
There is one US patent protecting INGENUS PHARMS LLC drugs. There is one tentative approval on INGENUS PHARMS LLC drugs.
There is one patent family member on INGENUS PHARMS LLC drugs in one country and fifteen supplementary protection certificates in seven countries.
Summary for Ingenus Pharms Llc
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 10 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 212501-001 | Jul 30, 2020 | RX | Yes | Yes | 10,993,952 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ingenus Pharms Llc | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 211011-001 | Jun 21, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ingenus Pharms Llc | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 209315-001 | Nov 15, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ingenus Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016132270 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ingenus Pharms Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2701720 | 301206 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/22/1669 20220818 |
| 0227494 | 95C0013 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910 |
| 0166287 | SPC/GB96/056 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
